• Christiaan Keijzer, Dirk R Buitelaar, Katina M Efthymiou, Michael Srámek, Julia ten Cate, May Ronday, Tino Stoppa, Johannes M Huitink, and Peter F Schutte.
• Department of Anesthesiology and Intensive Care, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. mail@keijzer.com
• Anesth. Analg. 2009 Oct 1;109(4):1092-5.

BackgroundMany supralaryngeal airway devices are available. Because of the absence of an inflatable cuff, we hypothesized that use of the i-gel should produce fewer postoperative throat and neck complaints compared with a standard disposable laryngeal mask (LM).MethodsTwo hundred eighteen patients were randomized to have either an i-gel or La Premiere LM airway placed for airway management. Patients were interviewed postoperatively for throat and neck complaints at 1, 24, and 48 h. Interviewers and patients were blinded to the device used.ResultsOne hundred nine patients had an i-gel and 103 had a La Premiere supraglottic device inserted. The incidence of sore throat was significantly lower with the i-gel than with LM at 1 (6 vs 32), 24 (7 vs 48), and 48 h (5 vs 25). Similar results were seen for dysphagia. The incidence of neck pain was also lower for the i-gel at 24 (1 vs 7) and 48 h (1 vs 7).ConclusionIn this randomized study, the i-gel supraglottic device resulted in a lower incidence of throat and neck complaints than the La Premiere LM airway.

25 keywords...

hide…